Does APALUTAMIDE Cause Metastases to bone? 45 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 45 reports of Metastases to bone have been filed in association with APALUTAMIDE (ERLEADA). This represents 0.5% of all adverse event reports for APALUTAMIDE.
45
Reports of Metastases to bone with APALUTAMIDE
0.5%
of all APALUTAMIDE reports
4
Deaths
9
Hospitalizations
How Dangerous Is Metastases to bone From APALUTAMIDE?
Of the 45 reports, 4 (8.9%) resulted in death, 9 (20.0%) required hospitalization, and 1 (2.2%) were considered life-threatening.
Is Metastases to bone Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APALUTAMIDE. However, 45 reports have been filed with the FAERS database.
What Other Side Effects Does APALUTAMIDE Cause?
Rash (1,117)
Death (1,008)
Fatigue (824)
Hot flush (532)
Product dose omission issue (384)
Diarrhoea (317)
Asthenia (303)
Dizziness (294)
Fall (268)
Off label use (257)
What Other Drugs Cause Metastases to bone?
LETROZOLE (1,735)
RIBOCICLIB (1,538)
FULVESTRANT (1,525)
ZOLEDRONIC ACID (1,087)
DENOSUMAB (1,053)
TAMOXIFEN (894)
LEUPROLIDE (848)
EVEROLIMUS (845)
PACLITAXEL (820)
PALBOCICLIB (793)
Which APALUTAMIDE Alternatives Have Lower Metastases to bone Risk?
APALUTAMIDE vs APATINIB
APALUTAMIDE vs APIDRA
APALUTAMIDE vs APIDRA SOLOSTAR
APALUTAMIDE vs APIXABAN
APALUTAMIDE vs APLISOL DIAGNOSTIC ANTIGEN